REGENERON PHARMACEUTICALS INC | 173,70 Euro | -1,873 -1,07 % | |
| WKN: 881535 ISIN: US75886F1075 Ticker-Symbol: RGO | Frankfurt | 20.06.13 | 08:06 Uhr |
Branche BiotechnologieAktienmarkt NASDAQ-100S&P 500 NASDAQ Biotech |
|
|
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 19.06. | Regeneron Pharma - Die zweite Chance | 3 | GodmodeTrader.de | |
| 14.06. | Regeneron Pharmaceuticals has the Highest Return on Equity in the Biotechnology Industry | 6 | SmarTrend | |
| 12.06. | Regeneron Pharmaceuticals Bearish Moving Average Crossover Alert | 4 | SmarTrend | |
| 12.06. | Zacks Investment Ideas feature highlights: Market Vectors Biotech ETF, iShares Nasdaq Biotechnology ETF, Regeneron, Celgene and First Trust Amex Biotechnology Index Fund | 16 | PR Newswire | |
| CHICAGO, June 12, 2013 /PRNewswire/ -- Today, Zacks Investment Ideas feature highlights Features: Market Vectors Biotech ETF (AMEX:BBH-Free Report), iShares Nasdaq Biotechnology ETF (Nasdaq:IBB-Free... Mehr lesen zu: Zacks Investment Ideas feature highlights: Market Vectors Biotech ETF, iShares Nasdaq Biotechnology ETF, Regeneron, Celgene and First Trust Amex Biotechnology Index Fund | ||||
| 11.06. | Regeneron Pharmaceuticals, Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 08:40 AM | 3 | Seeking Alpha | |
| 07.06. | Look for Shares of Regeneron Pharmaceuticals to Potentially Pullback after Yesterday's 2.11% Rise | 7 | SmarTrend | |
| 07.06. | Regeneron Pharma - So schnell kann es gehen | 41 | GodmodeTrader.de | |
| 06.06. | Regeneron Shares Jump As Eye Drug Meets New Study Goal | 10 | Barron's | |
| 06.06. | Regeneron (REGN) Continues Higher on Positive EYLEA Phase 3 Data | 2 | StreetInsider.com | |
| 06.06. | Regeneron and Bayer Announce Positive Phase 3 Results for EYLEA Injection | 5 | Benzinga.com | |
| 06.06. | Regeneron, Bayer Announce Positive Phase 3 Results For Eylea Injection In MCNV | 97 | AFX News | |
| LEVERKUSEN (dpa-AFX) - Regeneron Pharmaceuticals Inc. (REGN) and Bayer
HealthCare announced positive top-line results for Eylea or aflibercept
Injection from the Phase 3 Myrror study in... Mehr lesen zu: Regeneron, Bayer Announce Positive Phase 3 Results For Eylea Injection In MCNV | ||||
| 06.06. | Regeneron and Bayer Report Positive Phase 3 Results for EYLEA (aflibercept) Injection in Myopic Choroidal Neovascularization (mCNV) | 75 | PR Newswire | |
| TARRYTOWN, N.Y., June 06, 2013 /PRNewswire/ --Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced positive top-line results for EYLEA® (aflibercept) Injection from... Mehr lesen zu: Regeneron and Bayer Report Positive Phase 3 Results for EYLEA (aflibercept) Injection in Myopic Choroidal Neovascularization (mCNV) | ||||
| 03.06. | Regeneron Pharmaceuticals Falls 2.40% on Heavy Volume: Watch For Potential Rebound | 15 | SmarTrend | |
| 31.05. | UK cost agency recommends Bayer, Regeneron eye drug | 23 | Reuters.com | |
| 30.05. | Regeneron's Blockbuster Drug Eylea And Its Potential Competitors | 11 | Seeking Alpha | |
| 29.05. | Watch for Regeneron Pharmaceuticals to Potentially Rebound After Falling 1.49% Yesterday | 8 | SmarTrend | |
| 29.05. | Regeneron Pharmaceuticals, Inc. Presents at 38th Annual Deutsche Bank Health Care Conference, May-29-2013 08:40 AM | 2 | Seeking Alpha | |
| 28.05. | Clearing The Air On The Sanofi-Regeneron Asthma Drug Trial | 39 | Seeking Alpha | |
| 22.05. | Regeneron Shareholders Watching Optina Trial Closely | 18 | Seeking Alpha | |
| 22.05. | Bullish Moving Average Cross by Regeneron Pharmaceuticals | 9 | SmarTrend | |
Seite: 1 2 3 4 5 ... Weiter >>
197 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| MORPHOSYS | 37,855 | -1,64 % | MorphoSys AG: Veröffentlichung gem. § 26 Abs.1 WpHG mit dem Ziel der europaweiten Verbreitung |
| AMGEN | 74,52 | -1,95 % | Amgen Award For Science Teaching Excellence Honors Outstanding Teachers |
| QIAGEN | 14,565 | -1,49 % | Qiagen sichert sich weitere Rechte an Krebsbiomarkern |
| BB BIOTECH | 91,00 | -0,76 % | BB Biotech AG: Veröffentlichung gem. § 26 Abs.1 WpHG mit dem Ziel der europaweiten Verbreitung |
| BIOGEN IDEC | 152,65 | -2,30 % | Iconix Brand Group, Ralph Lauren, DaVita HealthCare Partners, Myriad Genetics and Biogen Idec highlighted as Zacks Bull and Bear of the Day |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von